Skip to NavigationSkip to content

News

New reports have suggested that the healthcare sector is embracing digital transformation and accelerating this development in their companies to...
AstraZeneca’s Phase 3 THALES trial showed that Brilinta (ticagrelor) significantly reduced the rate of death or stroke in patients with acute...
The Sandoz division of Novartis will not make a profit on the 15 generics it is making available to developing nations to help them deal with the...
The Trump administration has ordered hospitals to stop sending coronavirus patient data to the Centers for Disease Control and Prevention (CDC) and...
NICE has revealed its recommendation of Astellas’ gilteritinib for routine use as a monotherapy on the NHS in England and Wales for the treatment of...
Approval follows the drug hitting its primary goal in two Phase 3 studies.
A new study showed that the coronavirus infection rate hit its lowest point one month before lockdown restrictions were lifted.
The FDA’s Oncologic Drugs Advisory Committee (ODAC) has moved to recommend the use of GlaxoSmithKline’s belantamab mafodotin, or GSK2857916 as it is...
The first COVID-19 vaccine being used in clinical trials in the US is set to begin final testing.
The coronavirus news this week focuses on therapeutics, with Gilead’s remdesivir reducing the risk of death in 62% of severe COVID-19 patients, while...
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches